Summary
Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system. In 2021, there were 21,410 new cases of OC and 13,770 deaths. Remarkable progress has been made in ovarian cancer treatment, resulting in a 33% decline in mortality in the past few decades; unfortunately, equitable access to these therapies remains a challenge. While survival rates improved from 40% to 47% among non- Hispanic (NH) White women, survival has stagnated at 35% for NH-Black women. A well-established predictor of the ovarian cancer survival disparity is lack of access to quality treatmen
